Disease/Infection News

RSS

Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

In a recent article, longitudinal clinical phenotypes were described based on respiratory ordinal scales.

7 Jul 2022

The co-created challenges and opportunities of climate change and COVID-19 interactions

A new review aimed to highlight the opportunities as well as challenges of the interaction of COVID-19 and climate change.

7 Jul 2022

COVID-19 was the third leading cause of death in the US in 2020 and 2021

In a recent article published in the journal JAMA Internal Medicine, investigators examined the major causes of mortality across the United States (US) in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

7 Jul 2022

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

In a recent study under review at the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers identified immune priming conditions that generated broadly neutralizing antibody (nAb) responses and assessed immunity post-third dose of coronavirus disease 2019 (COVID-19) vaccines such as BNT126b2 or Coronavac vaccines after two homologous doses of BNT126b2 or Coronavac vaccines.

7 Jul 2022

TRIM7 inhibits coxsackievirus and norovirus infection

In a recent study posted to the bioRxiv* preprint server, researchers elucidated the underlying mechanisms of tripartite motif containing 7 (TRIM7) activity against coxsackievirus and norovirus.

7 Jul 2022

COVID-19 and brain damage explained

In a recent study published in the Brain journal, researchers in the United States analyzed the neurovascular injury in coronavirus disease 2019 (COVID-19).

7 Jul 2022

2022 monkeypox presents with new symptoms

In a recent study published in The Lancet Infectious Diseases, researchers described the clinical and demographical characteristics of monkeypox virus infections among individuals attending sexual health centers in the United Kingdom (UK).

6 Jul 2022

Chicoric acid a potential candidate for COVID-19 treatment

An article under review in the Scientific Reports journal and currently available on the Research Square* preprint server reports on chicoric acid (CA) as a potential inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2022

SARS-CoV-2 RBD vulnerability discovered - target for antibodies against variants

A new study successfully identified a potent neutralization epitope in SARS-related coronaviruses.

6 Jul 2022

COVID-19 impairs the insulin/IGF signaling pathway

Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.

6 Jul 2022

The role of myostatin in female fertility

A new study discusses some of the key functions of myostatin in female reproductive health and disease.

6 Jul 2022

Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa

Researchers evaluated the effects of age structure and vaccine prioritization regarding COVID-19 in West Africa.

6 Jul 2022

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

In a new study, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the SARS-CoV-2 receptor-binding domain against SARS-CoV-2 infection.

6 Jul 2022

Vaccination against smallpox efficiently protects against monkeypox infection

In a new study, researchers assessed the existing information regarding monkeypox infections.

6 Jul 2022

Scientists explore mutations in the SARS-CoV-2 receptor-binding domain

Researchers assessed the different mutations of concern in the SARS-CoV-2 receptor-binding domain.

6 Jul 2022

Omicron infections have similar incubation periods but shorter generation intervals than Delta infections

Researchers assessed the differences between the generation-interval distributions and incubation periods of the SARS-CoV-2 Delta and Omicron variants.

6 Jul 2022

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.

6 Jul 2022

Researchers reveal the exceptional capacity of Omicron to evade the immune system

The current wave of COVID-19 highlights a particularly high risk of reinfection by the Omicron variant of SARS-CoV-2.

6 Jul 2022

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

In a new study, the effectiveness of low low-density lipoprotein cholesterol levels in reducing the risk of atherosclerotic vascular events was explored.

6 Jul 2022

The host cell membrane binding surfaces of SARS-CoV-2 spike variants

Researchers identified SARS-CoV-2 spike surfaces involved in binding to host cell membranes.

6 Jul 2022

Disease/Infection News

Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

The co-created challenges and opportunities of climate change and COVID-19 interactions

COVID-19 was the third leading cause of death in the US in 2020 and 2021

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

TRIM7 inhibits coxsackievirus and norovirus infection

COVID-19 and brain damage explained

2022 monkeypox presents with new symptoms

Chicoric acid a potential candidate for COVID-19 treatment

SARS-CoV-2 RBD vulnerability discovered - target for antibodies against variants

COVID-19 impairs the insulin/IGF signaling pathway

The role of myostatin in female fertility

Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

Vaccination against smallpox efficiently protects against monkeypox infection

Scientists explore mutations in the SARS-CoV-2 receptor-binding domain

Omicron infections have similar incubation periods but shorter generation intervals than Delta infections

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

Researchers reveal the exceptional capacity of Omicron to evade the immune system

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

The host cell membrane binding surfaces of SARS-CoV-2 spike variants

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News